ZME Science on MSN
A new type of immunotherapy drug for prostate cancer shows up to 99% drop in cancer biomarkers
Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments have been game-changers for lung cancer and skin cancer, prostate cancer ...
Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.
The treatment, a type of immunotherapy which harnesses the body’s immune system to fight cancer, was found to shrink tumours ...
The average age of men who get diagnosed is 67.
Morning Overview on MSN
New prostate cancer immunotherapy slashes biomarkers by up to 99%
An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...
One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.
Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...
Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small ...
People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results